$Pfizer (PFE.US)$ guidance is conservative, but also set the...

$Pfizer(PFE.US)$ guidance is conservative, but also set the stage for the fourth quarter to beat expectations! -- The company raised its earnings guidance for fiscal 2021 to an adjusted $4.13 to $4.18 a share, up from $3.95 to $4.05 previously. Revenue outlook was raised to $81bn - $82bn from $78bn - $80bn.